NIH-funded research R01 grant

Predicting Psychosis Outcomes from Health Records

Official title: 2/5 Clinical Outcome Prediction of Psychosis from Electronic Health Records (COPPER)

Funded at New York Genome Center · NIH-11184424 · Data updated 2026-11-12

This project uses artificial intelligence to help predict future outcomes for people living with psychosis, aiming for more personalized care.

More Psychosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York Genome Center
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 6, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$639,892
NIH project number5R01MH137676-02
Project IDNIH-11184424 on NIH RePORTER

Who could benefit from this research

Could help

This work is relevant for individuals diagnosed with schizophrenia and other psychosis-related disorders, as it uses their health data to understand disease progression.

Less likely to help

Patients without a diagnosis of psychosis-related disorders would not directly benefit from the specific predictions developed by this project.

What this research studies

We are developing new ways to predict how psychosis might progress for individuals, using information from their electronic health records, detailed symptom patterns, and genetic data. Our goal is to create tools that can help doctors make more informed decisions about treatment plans and resource allocation. We also plan to look at the social and ethical considerations of using these types of predictions in mental health care. This work aims to bring personalized medicine to psychiatry, helping to tailor treatments and monitor progress more effectively.

Why it matters

Potential benefit: If successful, this work could lead to more personalized treatment plans and better monitoring for individuals with psychosis, potentially improving long-term outcomes and reducing side effects.

How similar studies have gone: While clinical predictors are common in other medical fields, their application in psychiatry, especially for psychosis outcomes using machine learning on EHRs, is a relatively new and developing area.

Where this research is happening

  • New York Genome Center
    New York, United States
    Active

Researchers

  • Principal investigator: Zody, Michael C — New York Genome Center
  • Study coordinator: Zody, Michael C

Related research

Other NIH-funded projects on the same topics.

  • Psychosis in diverse settings across the world

    This project studies how psychotic disorders show up and respond to treatment in adults with diverse backgrounds, including populations in Africa, the Caribbean, and other Global South settings.

    NIH research Suny Downstate Medical Center · Brooklyn, United States · NIH-11592428

  • Psychosis in Diverse Settings: Understanding Symptoms and Treatment Across Global South

    A human-facing study will look at how psychotic disorders present and respond to treatment in adults from Africa, the Caribbean, and other Global South settings, using genetic and clinical data.

    NIH research Suny Downstate Medical Center · Brooklyn, United States · NIH-11592427

  • A new online brain-scan-style tool to spot early psychosis risk

    A new online-based set of tasks and a computer model aims to identify people at high risk for developing psychosis earlier and more accurately.

    NIH research Northwestern University · Chicago, United States · NIH-11590585

  • Genetic clues for early-onset psychosis in Latino youth

    This project looks at the genes of young people with early-onset psychosis and compares them with similar youths without psychosis to find genetic factors that contribute to the illness.

    NIH research Boston Children's Hospital · Boston, United States · NIH-11554752

  • Biomarkers to tailor rehab for Veterans with schizophrenia

    A clinician-scientist is developing a brain-based biomarker to guide personalized rehabilitation for Veterans with schizophrenia.

    NIH research VA San Diego Healthcare System · San Diego, United States · NIH-11552825

  • Computational analysis of facial expression in early psychosis

    Aims to develop computer-based measures of facial expression in people at risk for or with schizophrenia to help track symptoms and guide future trials.

    NIH research Icahn School of Medicine at Mount Sinai · New York, United States · NIH-11539126

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.